Related Experiment Video
Updated: May 4, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
31.9K
Digital Mental Health Treatments for Depression
Giovanni Ramos1, Eirini Karyotaki2, David C Mohr3
1Department of Psychology, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA 94704, USA.
The Psychiatric Clinics of North America
|May 2, 2026
Summary
Digital mental health treatments (DMHTs) provide effective, accessible care for depression, comparable to traditional methods. Innovations aim to overcome challenges like poor engagement and integrate DMHTs as a frontline depression treatment.
Area of Science:
- Mental Health
- Digital Health
- Psychiatry
Background:
- Depression imposes a substantial global societal burden.
- Many individuals with depression do not receive adequate care.
- Digital mental health treatments (DMHTs) present a scalable solution.
Purpose of the Study:
- To review the effectiveness and challenges of DMHTs for depression.
- To explore innovations enhancing DMHT accessibility and integration.
- To position DMHTs as a primary treatment option.
Main Methods:
- Literature review of studies on DMHTs for depression.
- Analysis of DMHT effectiveness, acceptability, and satisfaction.
- Examination of barriers such as engagement and attrition.
- Evaluation of emerging innovations and their potential impact.
Main Results:
- DMHTs demonstrate effectiveness comparable to traditional therapies.
- High treatment acceptability and patient satisfaction are reported.
- Key challenges include poor engagement, high attrition, and limited clinical integration.
- Innovations like human support and AI show promise.
Conclusions:
- DMHTs are a viable and effective treatment for depression.
- Addressing engagement and integration barriers is crucial for wider adoption.
- Ongoing innovations are poised to enhance DMHTs' role in global mental healthcare.
Related Concept Videos
01:24Treatment Strategies for Psychological Disorders
977
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
977
01:27Depressive Disorders: MDD and Dysthymia
1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
01:28Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:30Electroconvulsive Therapy
2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K